Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease
Clinical trial NCT00552058 · COMPLETED
Trial details
- NCT number
- NCT00552058
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2009-10-01
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.